Exeter Financial, LLC Abb Vie Inc. Transaction History

Exeter Financial, LLC

$218 Million
Q1 2024

A detailed history of Exeter Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Exeter Financial, LLC holds 21,788 shares of ABBV stock, worth $3.62 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

21,788

Previous 21,986 0.9%

Holding current value

$3.62 Million

Previous $3.41 Million 16.44%

% of portfolio

1.82%

Previous 1.67%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $31,644 - $36,055	-198 Reduced 0.9%	21,788 $3.97 Million
Q4 2023 Jan 16, 2024	BUY	$137.6 - $154.97 $37,289 - $41,996	271 Added 1.25%	21,986 $3.41 Million
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $82,425 - $95,419	617 Added 2.92%	21,715 $3.24 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $64,002 - $79,646	483 Added 2.34%	21,098 $2.84 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $48,010 - $55,291	-332 Reduced 1.58%	20,615 $3.29 Million

Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $9,543 - $11,445	-69 Reduced 0.33%	20,947 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $86,297 - $98,976	643 Added 3.16%	21,016 $2.82 Million
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $15,551 - $19,770	-113 Reduced 0.55%	20,373 $3.12 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $171,574 - $212,875	-1,300 Reduced 5.97%	20,486 $3.32 Million
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $32,229 - $40,779	-300 Reduced 1.36%	21,786 $2.97 Million
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 0.45%	22,086 $2.38 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $71,610 - $78,834	700 Added 3.29%	21,986 $2.38 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $4,024 - $5,433	-50 Reduced 0.23%	21,286 $2.28 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $64,345 - $86,103	-877 Reduced 3.95%	21,336 $2.1 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $74,175 - $112,458	1,150 Added 5.46%	22,213 $1.69 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $22,288 - $27,887	-309 Reduced 1.45%	21,063 $1.87 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $36,135 - $46,189	550 Added 2.64%	21,372 $1.55 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $42,812 - $50,388	-555 Reduced 2.6%	20,822 $1.68 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $15,569 - $19,202	200 Added 0.94%	21,377 $1.97 Million
Q2 2018 Sep 24, 2018	BUY	$89.78 - $106.23 $26,934 - $31,869	300 Added 1.44%	21,177 $1.96 Million
Q1 2018 Sep 24, 2018	SELL	$92.01 - $123.21 $151,816 - $203,296	-1,650 Reduced 7.32%	20,877 $1.98 Million
Q4 2017 Sep 24, 2018	BUY	$89.56 - $98.21 $2.02 Million - $2.21 Million	22,527	22,527 $2.18 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exeter Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exeter Financial, LLC with notifications on news.

Account

Exeter Financial, LLC Abb Vie Inc. Transaction History